Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (759)	7/19/2005 12:08:01 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 1336

Sorry--the second quarter CC on Wedesday?? or "announced today it has signed an agreement with GE Healthcare for global distribution of Gene Logic's new SCIANTIS(TM) System, an online gene expression analysis system developed for use by academic, government and other non-profit research organizations" Sell on the news maybe? Not exactly a barnburner PR if the Yahooligans were waiting for buyout newsrelease. But if I had to guess, I would guess that earnings are not so good this quarter because of the expense of "increasing its general toxicology testing capacity by 55 percent..." and no new drug repositioning announcement. (edit) DPII--look at the valution for PCOP--I assume they are indeed in the same subsector, awful. Seems like everybody hates chemistry. It just isn't fair, heh.